Lunsumio

Roche reveals blood cancer plans post-COVID

Roche unveils its blood cancer strategy after COVID-19 boost

Anika Sharma

While Roche has seen a decline in COVID-19 drug sales after the pandemic boom, the company is experiencing a resurgence ...